Skip to Main Content Go to Sitemap
SickKids

News & Stories

Read the latest news and stories in the SickKids newsroom. Looking to interview someone? Connect with our media team.

This is a picture of a researcher in the lab.

September 21, 2020

SickKids-led research team discovers mechanism that leads leukemia cells to trigger bone loss, identifies a potential therapy to prevent it in lab models

Researchers have discovered a process that may trigger bone loss in patients with childhood B-ALL, and identified an antibody that helped to prevent it in the lab.

Photo of Dr. Upton Allen

September 15, 2020

Dr. Upton Allen from SickKids leads team assessing COVID-19 prevalence, risk factors among Black Canadian communities

Medical researchers from SickKids are conducting largescale antibody testing and data collection to understand the prevalence of COVID-19 infection in Black Canadian communities.

September 14, 2020

Researchers and teachers provide initial observations from school simulation study

SickKids researchers and teachers involved in a COVID-19 safe schools simulation study have compiled preliminary observations and key learnings from their experience.

Photo of a baby's milk bottle on a high chair.

September 4, 2020

Antibiotics affect breast milk microbiota in mothers of preterm infants, SickKids and U of T study shows

A team led by SickKids researchers and the University of Toronto has found that mothers of preterm babies have highly individual breast milk microbiomes, and that even short courses of antibiotics have prolonged effects on the diversity and abundance of microbes in their milk.

Boy in a classroom with a backpack

August 13, 2020

SickKids launching simulation study to assess impact of school-reopening health and safety measures

SickKids is leading a research study that will look at the effects of physical distancing, masking, hand hygiene and other health and safety measures for students and teachers returning to school during the COVID-19 pandemic.

COVID-19 coronavirus molecule

August 5, 2020

Joint statement on reopening schools

A joint statement from SickKids and other paediatric organizations on guidelines for the reopening of schools.

COVID-19 Recommendations for School Reopening report cover of kids

July 29, 2020

SickKids-led group of experts proposes latest guidance for school reopening

A group of experts from across Ontario have come together to develop updated considerations for a safe school reopening amid the COVID-19 pandemic.

Scans of a brain

July 27, 2020

SickKids and U of T researchers demonstrate drug stimulation of neural stem cell repair may lead to promising impact on treatment of childhood brain injury in survivors of brain cancer

 SickKids researchers have shown that metformin, a common drug used to treat type-2 diabetes, could one day be used to repair brain injury.

Ryan Yeun

July 27, 2020

SickKids scientists discover novel genetic contributors to autism

Breakthrough SickKids study of thousands of repetitive DNA “wrinkles” identifies previously hidden genetic alterations for the first time.

Photo Dr. Livia Loureiro

July 21, 2020

Government of Canada announces more than $16.5 million funding increase for SickKids-supported research facilities

Researchers at SickKids and several collaborating institutions are receiving a renewed investment, representing a combined increase of over $16.5 million, from the Major Science Initiatives (MSI) fund through the Canada Foundation for Innovation (CFI).

Illustration of a protein structure showing RRSP in blue and DTB in gold

July 10, 2020

SickKids researchers re-engineer toxin to attack previously “undruggable” cancer target

Researchers have developed a novel anti-cancer drug protein, which could lead to the development of future therapies for what was previously considered an “undruggable” target.

COVID-19 molecules

July 6, 2020

SickKids gradually increasing scheduled clinical care activity

SickKids will advance to the next phase of its restart of scheduled clinical care services impacted by COVID-19.

Follow us on Twitter

Back to Top